By introducing healthy copies of the beta-globin gene or using genome editing techniques to reactivate fetal hemoglobin production, gene therapy has the potential to cure SCA and eliminate its complications [20]. The gene discussed is HBB; the disease is autosomal dominant cerebellar ataxia.